Gosebruch Henry O.

Insider Reports History

Location
North Chicago, IL
Signature
/s/ Eddie Kim, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gosebruch Henry O.:

Company Role Class Num Shares Value Price $ Report Date Ownership
AbbVie Inc. EVP, Chief Strategy Officer Common Stock, $0.01 par value 53,500 $8,277,520 $154.72 16 May 2022 In trust
AbbVie Inc. EVP, Chief Strategy Officer Common Stock, $0.01 par value 41,623 $6,439,911 $154.72 16 May 2022 Direct
Neumora Therapeutics, Inc. President & CEO, Director Common Stock 462,345 $5,538,893 $11.98 14 Feb 2024 Direct
Neumora Therapeutics, Inc. President & CEO, Director Common Stock 127,448 $1,526,827 $11.98 14 Feb 2024 Indirect
AbbVie Inc. EVP, Chief Strategy Officer Common Stock, $0.01 par value 3,638 $562,871 $154.72 16 May 2022 Profit sharing trust
ACELYRIN, Inc. Director Common Stock 0 $0 $2.45 21 May 2025 Direct
Neumora Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 160,000 14 Feb 2024 Direct
Aptinyx Inc. Director Stock Option (Right to Buy) 40,000 26 May 2022 Direct
AbbVie Inc. EVP, Chief Strategy Officer Option (Right to Buy) 0 $144.54 16 May 2022 Direct
ACELYRIN, Inc. Director Director Stock Option (right to buy) 0 21 May 2025 Direct

Insider Reports Filed by Gosebruch Henry O.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLRN ACELYRIN, Inc. 21 May 2025 3 $0 4 Director 23 May 2025, 16:07
SLRN ACELYRIN, Inc. 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 19:11
NMRA Neumora Therapeutics, Inc. 14 Feb 2024 2 $0 4 President & CEO, Director 16 Feb 2024, 16:15
NMRA Neumora Therapeutics, Inc. 19 Sep 2023 1 +$189,370 4 President & CEO, Director 19 Sep 2023, 21:47
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 President & CEO, Director 14 Sep 2023, 18:58
SLRN ACELYRIN, Inc. 09 May 2023 3 +$900,000 4 Director 11 May 2023, 21:06
SLRN ACELYRIN, Inc. 04 May 2023 0 $0 3 Director 04 May 2023, 19:46
/report/000141588922005908-gosebruch-henry-o-2022-05-26 Aptinyx Inc. 26 May 2022 1 $0 4 Director 31 May 2022, 16:31
ABBV AbbVie Inc. 16 May 2022 3 -$13,013,800 4/A EVP, Chief Strategy Officer 20 May 2022, 17:03
ABBV AbbVie Inc. 01 Mar 2022 4 -$3,682,189 4/A EVP, Chief Strategy Officer 20 May 2022, 17:00
ABBV AbbVie Inc. 25 Feb 2022 4 -$6,733,364 4 EVP, Chief Strategy Officer 01 Mar 2022, 17:14
ABBV AbbVie Inc. 17 Feb 2022 5 $0 4 EVP, Chief Strategy Officer 22 Feb 2022, 16:39
ABBV AbbVie Inc. 07 Sep 2021 2 $0 4 EVP, Chief Strategy Officer 10 Sep 2021, 17:01
/report/000141588921002740-gosebruch-henry-o-2021-05-27 Aptinyx Inc. 27 May 2021 1 $0 4 Director 01 Jun 2021, 16:36